(2003) demonstrated that Epithalon increased telomerase activity in human somatic cells by 2.4-fold A 15-year follow-up study of elderly patients showed that those receiving peptide bioregulators (including Epithalon) had a 28% reduction in mortality compared to controls Animal studies have shown increased lifespan of up to 13.3% in organisms treated with Epithalon, as reported in research published through the National Institute on Aging Studies on retinal pigment epithelium cells showed Epithalons ability to reactivate telomerase in senescent cells While more large-scale human clinical trials are needed, the existing body of research is substantial and encouraging
I'm like, I'm a big Musk fan, but I don't have any desire, bro, to go to Mars or go to space
In an in vitro study conducted by Professor Khavinson and colleagues in 2003, the team demonstrated that epithalon elongates telomeres and induces telomerase activity when introduced to telomerase-negative human fetal fibroblast cultures
A 2.5 mg dose now equals 1.0 mL
More specifically, LDN modulates or regulates certain immune markers and lowers a pro-inflammatory cell known as TH17, which is an autoimmune promoter
ROS can induce autophagy through several mechanisms, including direct activation of AMP-activated protein kinase or inhibition of the mammalian target of rapamycin [163, 164]
